Contestación a «Experiencia con dulaglutida en un paciente diabético y obeso en diálisis peritoneal incremental». Respuesta a carta relacionada

IF 2 4区医学 Q2 UROLOGY & NEPHROLOGY

Nefrologia Pub Date : 2024-05-01 DOI:10.1016/j.nefro.2023.10.005

José C. de la Flor , Esperanza Moral , Javier Deira , Tania Monzón , Francisco Valga , Cristina Albarracín , Miguel Rodeles

引用次数: 0

查看原文本刊更多论文

对 "腹膜透析肥胖糖尿病患者使用度拉鲁肽的经验 "的回复回复相关信件

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nefrologia 医学-泌尿学与肾脏学

CiteScore

3.40

自引率

7.70%

发文量

148

审稿时长

47 days

期刊介绍： Nefrología is the official publication of the Spanish Society of Nephrology. The Journal publishes articles on basic or clinical research relating to nephrology, arterial hypertension, dialysis and kidney transplants. It is governed by the peer review system and all original papers are subject to internal assessment and external reviews. The journal accepts submissions of articles in English and in Spanish languages.